Torin W. Waters
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Torin W. Waters has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- David S. Dickens
The University of Iowa
2 shared publications Yutaka Sato
Division of Pediatric Radiology University of Iowa Hospitals and Clinics Iowa City Iowa
2 shared publicationsBrian Dlouhy
University of Iowa
1 shared publicationBrian J. Dlouhy
Department of Neurosurgery University of Iowa Hospitals and Clinics Iowa City Iowa
1 shared publicationMariko Sato
University of Iowa Children's Hospital
1 shared publication- Mariko Sato
Department of Pediatric Oncology, Children’s Hospital of Orange County, Orange, CA 92868, USA
1 shared publication
Latest Publications
- 31 July 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (11) , e29272
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia
Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long‐term neurocognitive effects of cumulative propofol exposure have raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID‐19 test prior to each sedated procedure.Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce postinduction sedated LPs by 50%. Our intervention included patient and family education, followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time, and LP success rates were collected for sedated and unsedated LPs.Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs. 83 minutes) for families, decreased expenditures ($5736 reduction per procedure), and improved institutional opportunity cost due to a decrease in last‐minute cancelations.Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.
- 31 July 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (11) , e29272
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia
Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long‐term neurocognitive effects of cumulative propofol exposure have raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID‐19 test prior to each sedated procedure.Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce postinduction sedated LPs by 50%. Our intervention included patient and family education, followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time, and LP success rates were collected for sedated and unsedated LPs.Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs. 83 minutes) for families, decreased expenditures ($5736 reduction per procedure), and improved institutional opportunity cost due to a decrease in last‐minute cancelations.Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.
- Open Access
- 29 June 2021
- Published by Wiley
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia
Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long-term neurocognitive effects of cumulative propofol exposure has raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID-19 test prior to each sedated procedure. Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce post-Induction sedated lumbar punctures (LPs) by 50%. Our intervention included patient and family education followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time and LP success rates were collected for sedated and unsedated LPs. Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48.1%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs 83 minutes) for families, decreased expenditures ($5,736.16 reduction per procedure) and improved institutional opportunity cost due to a decrease in last-minute cancellations. Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.
- 29 June 2021
- Published by Wiley
Open AccessReducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia
Background: Sedation for lumbar punctures (LPs) in pediatric acute lymphoblastic leukemia (ALL) patients has been the standard for decades to reduce pain and anxiety. Recent studies on the potential long-term neurocognitive effects of cumulative propofol exposure has raised concerns about this practice. The recent pandemic introduced additional burdens to patients, with the requirement of a negative COVID-19 test prior to each sedated procedure. Procedure: These factors prompted a quality improvement intervention at our institution where we aimed to reduce post-Induction sedated lumbar punctures (LPs) by 50%. Our intervention included patient and family education followed by a simulation of the procedure for selected patients. Those converted to unsedated LPs were queried for their preference. Comparative cost, clinical time and LP success rates were collected for sedated and unsedated LPs. Results: Following the intervention, the percentage of LPs performed with sedation dropped from 100% to 48.1%. All LPs were successful using both techniques. Most patients who experienced the unsedated LP technique, and their guardians, strongly preferred this approach. Unsedated LPs significantly reduced clinical time (169 vs 83 minutes) for families, decreased expenditures ($5,736.16 reduction per procedure) and improved institutional opportunity cost due to a decrease in last-minute cancellations. Conclusion: We have shown that it is feasible to significantly reduce the use of sedation for LPs in patients with ALL, which has the potential to improve health and patient experience at a lower cost.
- 5 January 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (5) , e28868
Refractory infantile high‐grade glioma containing TRK‐fusion responds to larotrectinib
- 5 January 2021
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 68 (5) , e28868
Refractory infantile high‐grade glioma containing TRK‐fusion responds to larotrectinib
- Open Access
- 11 September 2020
- Published by Wiley
Refractory infantile high-grade glioma containing TRK-fusion responds to larotrectinib
High-grade gliomas (HGGs) are a challenging group of brain tumors. Identification of targetable genetic alterations such as TRK fusions are providing new treatment options. We discuss an infant who presented with hydrocephalus and a cystic mass at birth, while a solid tumor component of the mass was only appreciated later. Tumor analysis was consistent with HGG containing a TRK fusion. Despite treatment with conventional chemotherapy, his tumor progressed in size. He was started on larotrectinib and experienced a significant decrease in tumor burden. This case demonstrates that targeted therapy may be effective for a subset of TRK fusion-positive CNS tumors.
- 11 September 2020
- Published by Wiley
Open AccessRefractory infantile high-grade glioma containing TRK-fusion responds to larotrectinib
High-grade gliomas (HGGs) are a challenging group of brain tumors. Identification of targetable genetic alterations such as TRK fusions are providing new treatment options. We discuss an infant who presented with hydrocephalus and a cystic mass at birth, while a solid tumor component of the mass was only appreciated later. Tumor analysis was consistent with HGG containing a TRK fusion. Despite treatment with conventional chemotherapy, his tumor progressed in size. He was started on larotrectinib and experienced a significant decrease in tumor burden. This case demonstrates that targeted therapy may be effective for a subset of TRK fusion-positive CNS tumors.